Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Beth Stevens
University of California Los Angeles, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Annexon Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Stevens serves on the Scientific Advisory Board of Annexon, and is the PI.
Complement-Microglia Interaction in Synaptic Loss and Neurodegeneration in HD
Huntington's disease (HD) is one of the most common inherited fatal neurodegenerative disorders characterized by progressive motor, cognitive, and psychiatric symptoms. Our proposed study is based on new findings on the influence of complement factors and their interaction with resident innate immune cells in the brain in pathogenesis of HD-like progressive movement disorder and neurodegeneration. Elucidating the precise underlying mechanisms and validating the disease impact of complement factors in independent HD mouse models may provide a novel therapeutic strategy for HD and related age-dependent neurodegenerative disorders.
Filed on April 25, 2017.
Tell us what you know about Beth Stevens's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Beth Stevens filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Beth Stevens | Boston Children's Hospital | Conflict of Interest | Annexon Biosciences | $10,000 - $19,999 |
| Beth Stevens | Boston Children's Hospital | Conflict of Interest | Annexon Biosciences | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.